PRICE ANALYSIS OF NEW NERVOUS SYSTEM DRUGS MARKETED IN THE US (1980-2021)

被引：0
|
作者：
Bukhari, K. [1 ]
Seoane-Vazquez, E. [2 ]
机构：
[1] Chapman Univ, Irvine, CA USA
[2] Chapman Univ, Sch Pharm, Irvine, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR40
引用
下载
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [31] TRACKING THE SPONSORING COUNTRY OF INCORPORATION FOR NEW DRUGS APPROVED BY THE US FDA IN THE PERIOD 1980-2014: A TREND ANALYSIS
    Alqahtani, S. S.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    Eguale, T.
    Zeukeng, M. J.
    Szeinbach, S.
    VALUE IN HEALTH, 2015, 18 (03) : A72 - A72
  • [32] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 867 - 885
  • [33] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (08) : 867 - 885
  • [34] ARECOLINE PHENOMENON IN THE ANALYSIS OF THE ACTION OF DRUGS ON CENTRAL NERVOUS SYSTEM
    KHARAUZOV, NA
    INTERNATIONAL JOURNAL OF NEUROPHARMACOLOGY, 1964, 3 (05): : 489 - 492
  • [35] Cost Analysis of Different Brands of New in Class Anti-Anginal drugs Marketed in India
    Singh, Soujania G.
    Elizabeth, Arul Amutha
    Brigida, S.
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (10): : 175 - 178
  • [36] Correction to: A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 383 - 383
  • [37] Efficacy, safety and cost of new drugs acting on the central nervous system
    Garattini, S
    Bertele, V
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (01) : 79 - 84
  • [38] Efficacy, safety and cost of new drugs acting on the central nervous system
    Silvio Garattini
    Vittorio Bertele'
    European Journal of Clinical Pharmacology, 2003, 59 : 79 - 84
  • [39] Safety of cardiovascular disease drugs approved between 2014 and 2021 in the US: a pharmacovigilance analysis
    Park, Taehwan
    Hwang, Monica
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2024, 22 (06) : 273 - 283
  • [40] Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs
    Doan, KMM
    Humphreys, JE
    Webster, LO
    Wring, SA
    Shampine, LJ
    Serabjit-Singh, CJ
    Adkison, KK
    Polli, JW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03): : 1029 - 1037
12345